bioMérieux
BIM.PADrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Probiotic | Phase 3 | Acute Gastroenteritis | - | - |
Frequently asked questions
What is in bioMérieux's drug pipeline?→
CatalystAlert tracks 1 drug candidate in bioMérieux's (BIM.PA) pipeline across Phase 3. Its lead program is Probiotic (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is bioMérieux's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for bioMérieux (BIM.PA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track BIM.PA biotech catalysts?→
Add BIM.PA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow bioMérieux's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.